scispace - formally typeset
F

Fumitaka Takeshita

Researcher at National Cancer Research Institute

Publications -  94
Citations -  11036

Fumitaka Takeshita is an academic researcher from National Cancer Research Institute. The author has contributed to research in topics: Cancer & Metastasis. The author has an hindex of 40, co-authored 90 publications receiving 9520 citations. Previous affiliations of Fumitaka Takeshita include Osaka University.

Papers
More filters
Journal ArticleDOI

Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells

TL;DR: It is shown that miRNAs are released through a ceramide-dependent secretory machinery and that the secretory miRNAAs are transferable and functional in the recipient cells and that a tumor-suppressive miRNA secreted via this pathway was transported between cells and exerted gene silencing in the recipients cells, thereby leading to cell growth inhibition.
Journal ArticleDOI

Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis.

TL;DR: It is demonstrated that the neutral sphyngomyelinase 2 (nSMase2) regulates exosomal microRNA (miRNA) secretion and promotes angiogenesis within the tumor microenvironment as well as metastasis, suggesting that the horizontal transfer of exosome miRNAs from cancer cells can dictate the microenviromental niche for the benefit of the cancer cell.
Journal ArticleDOI

Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes.

TL;DR: Adipose tissue is a source of multipotent stem cells that can be easily isolated, selected, and induced into mature, transplantable hepatocytes, and the fact that they are easy to procure ex vivo in large numbers makes them an attractive tool for clinical studies in the context of establishing an alternative therapy for liver dysfunction.
Journal ArticleDOI

Emerging roles of long non-coding RNA in cancer.

TL;DR: This article aims to outline different cancer‐associated lncRNA according to their contribution to tumor suppression or tumor promotion based on their most current functional annotations.